ScienceDaily (Mar. 23, 2007) — The National Institute of Standards and Technology (NIST) has developed a new reference material to help improve the accuracy of clinical diagnostic tests for chronic kidney disease. The new Standard Reference Material (SRM) consists of samples of frozen human blood serum certified by NIST for two different concentrations of creatinine.

Chronic kidney disease (CKD) is a growing problem in the United States. It can be caused by high blood pressure, diabetes and other disorders. If left untreated, it eventually can lead to kidney failure. The National Kidney Disease Outcome Quality Initiative* reported that end-stage renal disease has dramatically increased in the past two decades, and estimated that close to 20 million Americans probably have early stages of CKD.

Timely diagnosis is a significant problem. Kidney function is measured by "glomerular filtration rate" (GFR), which provides an estimate of how well the kidneys are removing waste and excess fluid from the blood. GFR cannot be measured directly in a clinical setting, so instead physicians test for blood serum levels of creatinine, a metabolic by-product of muscles.

Plugging the creatinine level into an equation that factors in other variables, including age, gender and race, yields an estimated GFR value. Detecting relatively small changes in serum creatinine levels is key to early diagnosis of CKD, but studies summarized in a recent paper** from the National Kidney Disease Education Program (NKDEP, an initiative of the National Institutes of Health) noted that the current variability in serum creatinine measurements is too large to detect small increases in creatinine.

The new NIST SRM 967, Creatinine in Frozen Human Serum, was developed in collaboration with the NKDEP and the College of American Pathologists (CAP) to meet the need for improved calibration of clinical instruments and procedures for measuring serum creatinine. The SRM consists of frozen human serum with two different levels of creatinine. Level 1 (0.75 mg/dL) is within the normal range of serum creatinine levels, while Level 2 (3.92 mg/dL) is intended to correspond to levels found in chronic kidney disease.

Reference: G.L. Myers, W.G. Miller, J. Coresh, J. Fleming, N. Greenberg, T. Greene, T. Hostetter, A.S. Levey, M. Panteghini, M. Welch, and J.H. Eckfeldt. Recommendations for improving serum creatinine measurement: A report from the laboratory working group of the National Kidney Disease Education Program. Clinical Chemistry 2006 52: 5-18.

Story Source:

Adapted from materials provided by National Institute of Standards and Technology (NIST).

Related Stories

New NIST Reference Material Reinforces Fragile-X Screens (Mar. 1, 2005) — A new Standard Reference Material from the National Institute of Standards and Technology (NIST) will help clinical genetics labs improve the accuracy of their diagnostic tests for the most common ...  > read more

Newly Improved NIST Reference Material Targets Infant Formula Analysis (Aug. 26, 2009) — Chemists at NIST have issued a new certified reference material -- a standardized sample backed by NIST -- for determining the concentrations of vitamins, minerals and other nutrients in infant and ...  > read more

Novel Markers For Kidney Disease Progression (May 22, 2009) — Scientists have established novel markers of kidney disease ...  > read more

Toward An 'Electronic Nose' To Sniff Out Kidney Disease In Exhaled Breath (June 19, 2009) — Scientists have identified the key substances in exhaled breath associated with healthy and diseased kidneys — raising expectations, they say, for development of long-sought diagnostic and ...  > read more

New Reference Material Can Improve Testing Of Multivitamin Tablets (Feb. 21, 2009) — NIST has developed a new certified reference material that can be an important quality assurance tool for measuring the amounts of vitamins, carotenoids and trace elements in dietary ...  > read more

Search ScienceDaily

Kidney Exchange